News & Events
Signs of MS may start five years before diagnosis
Canadian research shows people with MS are more likely than the general population to visit a doctor…
Study suggests improvement in MS employment outcomes
New research, involving 874 people who had used disease-modifying therapies during the previous 5 years, has shown…
Primary progressive MS risk may be linked to genes that cause other brain diseases
Genetic screening of people with primary progressive MS has shown that four rare genetic changes, which are…
‘Rings of fire’: blocking the death of brain cells in MS
A new study that suggests inflammation may lead to the death of brain cells in MS may…
New Zealand launches country’s first MS registry
The New Zealand Multiple Sclerosis Research Trust invited Professor Helmut Butzkueven, Managing Director of MSBase, to launch…
Join our team – Capacity Building Support Officer (Arab region)
Temporary part-time role to support our Arab region capacity building work
Highlights from the Cykelnerven cycling challenge
Daniel Magson, Fundraising Campaigns Manager at MSIF, shares the highlights from Cykelnerven, a new and unique charity…
ARSEP awards 1.6m EUR to MS research proposals
The Scientific Committee of the French MS Research Support Foundation (ARSEP) has selected recipients for its annual…
Over 20,000 people sign UK MS Society’s petition to improve disability benefit for people with MS
The UK MS Society’s campaign calls on the government to change criteria of Personal Independence Payments (PIP),…
Natalizumab treatment may preserve upper limb function in secondary progressive MS
Results from a trial of natalizumab in secondary progressive MS suggest anti-inflammatory treatments could slow disability accumulation,…
Clinical trial shows pilates can help mobility and walking in MS
Trial results show that Pilates, an exercise for strengthening core muscles, improves walking distance and mobility in…